[go: up one dir, main page]

NO20080392L - Pyrazolpyridinderivater som inhibitorer av beta-adrenergisk receptorkinase 1 - Google Patents

Pyrazolpyridinderivater som inhibitorer av beta-adrenergisk receptorkinase 1

Info

Publication number
NO20080392L
NO20080392L NO20080392A NO20080392A NO20080392L NO 20080392 L NO20080392 L NO 20080392L NO 20080392 A NO20080392 A NO 20080392A NO 20080392 A NO20080392 A NO 20080392A NO 20080392 L NO20080392 L NO 20080392L
Authority
NO
Norway
Prior art keywords
inhibitors
adrenergic receptor
receptor kinase
beta
pyridine derivatives
Prior art date
Application number
NO20080392A
Other languages
English (en)
Inventor
Marcel Patek
Martin Smrcina
Henning Steinhagen
Jochen Huber
Kurt Ritter
Bernard Pirard
Kirsten Bjergarde
Linli Wei
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20080392L publication Critical patent/NO20080392L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Foreliggende oppfinnelse angår 6-amidosubstituerte pyrazolopyridinderivater med formelen (I) anvendelige som inhibitorer av ß-adrenergisk reseptorkinase-1 (ß-ARK-1), sammensetninger inneholdende slike forbindelser og deres anvendelse for behandlingen og hindring av kronisk hjertesvikt, hypertensjon, myokardisk iskemi, hepatitt C virus (HCV) infeksjoner og for hindringen av opiatavhengighet.
NO20080392A 2005-06-27 2008-01-21 Pyrazolpyridinderivater som inhibitorer av beta-adrenergisk receptorkinase 1 NO20080392L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05013774 2005-06-27
PCT/EP2006/005649 WO2007000241A1 (en) 2005-06-27 2006-06-13 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1

Publications (1)

Publication Number Publication Date
NO20080392L true NO20080392L (no) 2008-02-28

Family

ID=35395578

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080392A NO20080392L (no) 2005-06-27 2008-01-21 Pyrazolpyridinderivater som inhibitorer av beta-adrenergisk receptorkinase 1

Country Status (30)

Country Link
US (1) US7910602B2 (no)
EP (1) EP1899333B1 (no)
JP (1) JP5010594B2 (no)
KR (1) KR20080020638A (no)
CN (1) CN101208340B (no)
AR (1) AR054514A1 (no)
AT (1) ATE423118T1 (no)
AU (1) AU2006264044A1 (no)
BR (1) BRPI0612320A2 (no)
CA (1) CA2611296A1 (no)
CY (1) CY1110464T1 (no)
DE (1) DE602006005242D1 (no)
DK (1) DK1899333T3 (no)
ES (1) ES2322197T3 (no)
HR (1) HRP20090244T2 (no)
IL (1) IL188381A0 (no)
MA (1) MA29498B1 (no)
MX (1) MX2007015829A (no)
MY (1) MY139016A (no)
NO (1) NO20080392L (no)
NZ (1) NZ564757A (no)
PL (1) PL1899333T3 (no)
PT (1) PT1899333E (no)
RS (1) RS50821B (no)
RU (1) RU2415855C2 (no)
SI (1) SI1899333T1 (no)
TW (1) TW200800982A (no)
UY (1) UY29632A1 (no)
WO (1) WO2007000241A1 (no)
ZA (1) ZA200709853B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200815438A (en) 2006-06-13 2008-04-01 Bayer Schering Pharma Ag Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
CA2716898A1 (en) * 2008-02-27 2009-09-03 Takeda Pharmaceutical Company Limited Compound having 6-membered aromatic ring
US9321787B2 (en) * 2011-07-07 2016-04-26 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
CA2905242C (en) 2013-03-15 2016-11-29 Pfizer Inc. Indole compounds that activate ampk
GB201410815D0 (en) * 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven Therapeutic agents
WO2020086505A1 (en) 2018-10-24 2020-04-30 Bristol-Myers Squibb Company Substituted indole dimer compounds
WO2020086503A1 (en) * 2018-10-24 2020-04-30 Bristol-Myers Squibb Company Substituted indole and indazole compounds
KR20220006571A (ko) 2019-05-09 2022-01-17 브리스톨-마이어스 스큅 컴퍼니 치환된 벤즈이미다졸론 화합물
CN114761404B (zh) 2019-10-01 2025-02-21 百时美施贵宝公司 经取代的双环杂芳基化合物
KR20220079587A (ko) 2019-10-04 2022-06-13 브리스톨-마이어스 스큅 컴퍼니 치환된 카르바졸 화합물
WO2024137671A1 (en) * 2022-12-20 2024-06-27 Exelixis, Inc. Compounds that inhibit pkmyt1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69510940T2 (de) * 1994-06-16 1999-11-11 Pfizer Inc., New York Pyrazolo und pyrrolopyridine
CA2314355A1 (en) * 1997-12-13 1999-06-24 Bristol-Myers Squibb Company Use of pyrazolo ¢3,4-b! pyridine as cyclin dependent kinase inhibitors
JP2002020386A (ja) * 2000-07-07 2002-01-23 Ono Pharmaceut Co Ltd ピラゾロピリジン誘導体
WO2003068773A1 (en) * 2002-02-12 2003-08-21 Glaxo Group Limited Pyrazolopyridine derivatives
CN1675209A (zh) * 2002-08-07 2005-09-28 三菱制药株式会社 二氢吡唑并吡啶化合物
RU2359971C2 (ru) * 2003-02-27 2009-06-27 Палау Фарма, С.А. Производные пиразолопиридина

Also Published As

Publication number Publication date
ZA200709853B (en) 2008-12-31
KR20080020638A (ko) 2008-03-05
RU2008102970A (ru) 2009-08-10
HRP20090244T2 (hr) 2009-07-31
UY29632A1 (es) 2007-01-31
MY139016A (en) 2009-08-28
DK1899333T3 (da) 2009-06-15
BRPI0612320A2 (pt) 2010-11-09
EP1899333B1 (en) 2009-02-18
AU2006264044A1 (en) 2007-01-04
JP2008543957A (ja) 2008-12-04
JP5010594B2 (ja) 2012-08-29
DE602006005242D1 (de) 2009-04-02
HRP20090244T1 (en) 2009-06-30
WO2007000241A1 (en) 2007-01-04
ATE423118T1 (de) 2009-03-15
RU2415855C2 (ru) 2011-04-10
MA29498B1 (fr) 2008-05-02
TW200800982A (en) 2008-01-01
CA2611296A1 (en) 2007-01-04
ES2322197T3 (es) 2009-06-17
NZ564757A (en) 2009-12-24
US7910602B2 (en) 2011-03-22
EP1899333A1 (en) 2008-03-19
IL188381A0 (en) 2008-04-13
PL1899333T3 (pl) 2009-07-31
CN101208340A (zh) 2008-06-25
RS50821B (sr) 2010-08-31
CN101208340B (zh) 2010-12-22
US20080227777A1 (en) 2008-09-18
AR054514A1 (es) 2007-06-27
MX2007015829A (es) 2008-02-22
SI1899333T1 (sl) 2009-08-31
CY1110464T1 (el) 2015-04-29
PT1899333E (pt) 2009-04-23

Similar Documents

Publication Publication Date Title
NO20080392L (no) Pyrazolpyridinderivater som inhibitorer av beta-adrenergisk receptorkinase 1
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20090835L (no) Nye HIV-reverstranskriptaseinhibitorer
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
NO20082508L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
NO20092130L (no) Tricykliske heteroarylforbindelser anvendelige som inhibitorer of januskinase
NO20065727L (no) Pyrrolinhibitorer av erk-proteinkinase, syntese derav og deres mellomprodukter
NO20091326L (no) Indazolderivater som modulatorer av interleukin-1-reseptor-assosiert kinase
NO20052595L (no) Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser.
NO20064976L (no) Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser
NO20071619L (no) Fremgangsmate for fremstilling av indazol forbindelse
NO20053470L (no) Triazolopyridaziner som proteinkinase-inhibitorer
MY148634A (en) Pyridazinone derivatives
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
NO20083923L (no) Pyrazolkinoloner er potente parp-inhibitorer
TNSN07252A1 (en) Indole derivatives for treating viral infections
NO20083918L (no) Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser
NO20072235L (no) HCV-hemmende bicykliske pyrimidiner
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
WO2007008704A3 (en) Melanocortin receptor ligands
ATE554087T1 (de) Neue kinaseinhibitoren
PL1899329T3 (pl) Pirymidyno-podstawione pochodne benzimidazolu jako inhibitory kinaz białkowych
NO20083501L (no) Azaindoler som er anvendelige som inhibitorer for Janus-kinaser
NO20084912L (no) Bisykliske derivater som CETP-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application